Formulations and clinical trial materials lead Piramal's new Ahmedabad facility

Published: 10-Feb-2009 Featured companies: Piramal Pharma Solutions
Regulatory

Piramal Pharma Solutions is on schedule to commission a new state of the art formulations development and clinical trial materials (CTM) supply centre at Ahmedabad, India. The centre will have GMP supply capabilities from March onwards.


Piramal Pharma Solutions is on schedule to commission a new state of the art formulations development and clinical trial materials (CTM) supply centre at Ahmedabad, India. The centre will have GMP supply capabilities from March onwards.

Located in Ahmedabad's Special Export Promotion (SEZ) Zone, the centre has a total footprint of 50,000ft2, of which half will be built out in Phase I. Initially, more than 34 formulators and 48 analytical chemists will be based at the centre - with plans to increase to a total of 180 over two phases.

The facility will provide the full suite of services, including formulations development, analytical development and validation, CTM supply, exhibit batches and ICH stability studies. It is equipped with state of the art, instrumented equipment for early phase solids formulations development and CTM supply.

Ten GMP suites with dedicated air handling units will allow work simultaneously on several projects. Separate suites are being built out with "Low RH" capability as well as ability to handle high potency actives.

"The latest development in Ahmedabad signals the continuing upgrade in our clinical trials manufacturing and services capabilities," said Dr R. Ananthanarayanan, president and head for Piramal Pharma Solutions. "The programme marks further expansion of our synthesis-to-market supply chain, with further elements due for announcement later this year."

Featured companies

Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life...
See more

You may also like

Regulatory

Paradigm shift: Remote audits during the COVID pandemic

Read more
Here John Athayde and Monika Bornani at Piramal Pharma Solutions discuss how even in the post-pandemic world, remote audits have great potential to become the preferred option

Trending Articles

  1. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena
  2. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  3. 4SC AG receives Paediatric Investigation Plan waiver for resminostat from the UK MHRA The waiver allows the company to avoid investigating the CTCL drug in a paediatric population, as it's considered unnecessary or inappropriate for use by this patient group
  4. Highly potent APIs: Hazards in classification and handling This variability and subjective nature of classification means that the OEL is best considered as a tool for site risk management teams
  5. Innovating with purpose for safety and security of outcome Beyond the importance of increasing productivity and generating more output and value with the same input, new ideas and technologies from GEA take innovation a step further

Relevant companies

See more

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Regulatory

Paradigm shift: Remote audits during the COVID pandemic

Here John Athayde and Monika Bornani at Piramal Pharma Solutions discuss how even in the post-pandemic world, remote audits have great potential to become the preferred option
Regulatory

Building a culture of safety and safety psychology within an organisation

Here Bharat N Londhe, Environment Health and Safety at Pirimal discusses the importance of safety culture
Regulatory

Spotlight on Piramal Pharma Solutions, USA

Taking a closer look at the company's facility in Lexington, KY USA
Regulatory

How to develop a successful regulatory partnership with a CDMO

Piramal Pharma Solutions is a CDMO offering end-to-end development and manufacturing solutions across the drug life cycle. Here Minoo Biju, Head of Regulatory Affairs at Piramal explores how business's can build successful regulatory partnerships
Manufacturing

Spotlight on Piramal Pharma Solutions, Scotland

Taking a closer look at the company's facility in Grangemouth
Regulatory

Could QBD fear slow a breakthrough therapy's speed to market?

Piramal Pharma Solutions have a published a white paper on how to apply the principles of Quality by Design (QBD) to the drug development process
Manufacturing

Piramal Pharma Solutions wins a prestigious CPhI Pharma Award

Piramal Pharma Solutions (PPS) was recognised as the winner of the Regulatory Procedures and Compliance award at the prestigious CPhI Pharma Awards (2017) on 24 October at the Intercontinental Hotel — Frankfurt, Germany
Subscribe now